Why the study?
Secondary mitral regurgitation from left ventricular dysfunction in severe heart failure is challenging to manage and often culminates in refractory pulmonary edema and multi-organ failure.
Does percutaneous MitraClip implantation enable weaning from extracorporeal membrane oxygenation in a patient with cardiogenic shock and severe secondary mitral regurgitation?
Case Report (n=1)
Does percutaneous MitraClip implantation enable weaning from extracorporeal membrane oxygenation in a patient with cardiogenic shock and severe secondary mitral regurgitation?
MitraClip implantation can serve as an effective bailout strategy to stabilize patients in cardiogenic shock with severe secondary MR, enabling weaning from mechanical support and serving as a bridge to LVAD.
Secondary mitral valve regurgitation is a frequent consequence of left ventricular dysfunction in patients with severe heart failure. The management of this disease can be challenging since it often culminates in refractory pulmonary edema and multi-organ failure. We present the case of a 50-year-old male who was admitted in cardiogenic shock following myocardial infarction. After successful revascularization, percutaneous mitral valve repair using the MitraClip ® device enabled weaning from extracorporeal membrane oxygenation followed by the implantation of a left ventricular assist device as bridge to transplant.
No takes yet. Share an insight, caveat, or question.
Schmiady et al. (2022) conducted a case report in Severe secondary mitral valve regurgitation with cardiogenic shock (n=1). Percutaneous mitral valve repair (MitraClip) was evaluated on Successful weaning from mechanical circulatory support and transition to LVAD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: